By Gina Shaw
Two new studies led by researchers from the Perelman School of Medicine at the University of Pennsylvania, in Philadelphia, have found that cost-sharing arrangements such as coinsurance are associated with significant reductions in access to specialty medications.
Two new studies led by researchers from the Perelman School of Medicine at the University of Pennsylvania, in Philadelphia, have found that cost-sharing arrangements such as coinsurance are associated with significant reductions in access to specialty medications.
In the first study (Am J Manag Care 2016;22[3]:188-197), the group reviewed published analyses of specialty drug cost sharing for the three conditions that attract the largest proportion of specialty drug spending: